bioAffinity Technologies, Inc. BIAF 深 沪
等待开盘 09-17 09:30:00 美东时间
0.261
-0.089
-25.51%
华盛通- 最 高0.3081
- 今 开0.3047
- 成交量 1395.84万股
- 最 低 0.25
- 昨 收 0.3504
- 总市值 743.03万
- 52周最高 2.2372
- 市盈率 静 --
- 换手率 0.05%
- 52周最低 0.1639
- 委 比 66.67%
- 总股本 2846.86万
- 历史最高 15.55
- 量 比 0.34
- 振 幅 16.58%
- 历史最低 0.1639
- 每 手 1
- 风险率 0.54%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多bioAffinity Technologies shares are trading higher after the company announced it received a notice of allowance for a U.S. patent titled "DETECTION OF EARLY-STAGE LUNG CANCER IN SPUTUM USING AUTOMATED FLOW CYTOMETRY AND MACHINE LEARNING"
bioAffinity Technologies shares are trading higher after the company announced ...
09-13 04:08
bioAffinity Technologies Unveils New CyPath® Lung Case Study
bioAffinity Technologies, Inc. ( ($BIAF) ) just unveiled an update. On Septembe...
09-10 04:56
U.S. Medicine Features bioAffinity's CyPath Lung Test For Enhanced VA Lung Cancer Detection And Cost Reduction
Noninvasive diagnostic can help federal medical system address veterans at higher risk for developing lung cancerU.S. Medicine, a leading publication for federal healthcare professionals, has featured bioAffinity
09-03 20:13
bioAffinity Amends Warrant Floor Price in Recent Agreement
bioAffinity Technologies, Inc. ( ($BIAF) ) just unveiled an update. On Septembe...
09-02 21:54
bioAffinity Technologies Appoints New Board Members
bioAffinity Technologies, Inc. ( ($BIAF) ) has provided an announcement. On Aug...
08-19 04:53
bioAffinity Technologies Q2 EPS $(0.17) Misses $(0.10) Estimate, Sales $1.269M Miss $1.506M Estimate
bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.10) by 70 percent. This is a 10.53 percent increase over losses of $(0.19) per
08-14 20:03
bioAffinity Technologies announces pricing of private placement
bioAffinity Technologies (NASDAQ:BIAF) announced on Wednesday that it has entered into securities purchase agreements for the purchase and sale of 990 shares of its Series B convertible preferred stoc...
08-13 22:11
bioAffinity Technologies Announces $1.2M Capital Raise Through Private Placement Of 990 Series B Preferred Shares Convertible Into 4.3M Common Shares At $0.23/Share And 6.7M Warrants At $0.352/Share, Plus $253K Warrant Inducement For Immediate Exercise Of 1.1M Existing Warrants And Issuance Of 1.43M New Warrants
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it has entered into securities
08-13 21:29
bioAffinity’s CyPath® Lung Test Identifies Missed Tumor
The latest announcement is out from bioAffinity Technologies, Inc. ( ($BIAF) )....
07-24 05:21
bioAffinity Technologies Secures Canadian Patent for Lung Cancer Detection
bioAffinity Technologies, Inc. ( ($BIAF) ) just unveiled an update. On July 22,...
07-23 05:04
